Newbridge Financial Services Group, Inc. Takeda Pharmaceutical CO LTD Transaction History

Newbridge Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 28, 2024	SELL	$13.36 - $15.43 $1,883 - $2,175	-141 Reduced 42.22%	193 $2,000
Q3 2023 Oct 17, 2023	BUY	$15.03 - $16.32 $30 - $32	2 Added 0.6%	334 $5,000
Q4 2022 Jan 17, 2023	BUY	$12.42 - $15.62 $37 - $46	3 Added 0.91%	332 $0
Q3 2022 Oct 13, 2022	BUY	$12.8 - $28.65 $25 - $57	2 Added 0.61%	329 $4,000
Q4 2021 Jan 19, 2022	BUY	$13.17 - $16.4 $2,581 - $3,214	196 Added 149.62%	327 $4,000
Q3 2021 Oct 27, 2021	BUY	$16.3 - $17.26 $48 - $51	3 Added 2.34%	131 $2,000
Q1 2021 Sep 07, 2021	BUY	$16.71 - $19.9 $2,138 - $2,547	128 New	128 $2,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.